Bard Access Systems Recalls DuoGlide Dialysis Catheter
Areazine synthesizes this FDA recall directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.
Bard Access Systems, Inc. is recalling 310 units of the DuoGlide Short-Term Straight Dialysis Catheter due to a supplier issue with lidocaine ampoules.
What this FDA recall tells you, and what most readers miss
This notice was issued by FDA on August 7, 2026 and geographically references United States. Its severity classification of "medium" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - FDA Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are recall, product-safety, fda, Devices.
What Happened
Bard Access Systems, Inc. initiated a voluntary recall of the DuoGlide Short-Term Straight Dialysis Catheter because lidocaine ampoules included with the product were manufactured under deficient manufacturing practices by the supplier.
Which Products Are Affected
The recall affects 310 units of product 5625240 DuoGlide Short-Term Straight Dialysis Catheter 13 Fr Dual-Lumen (UDI-DI Code: 00801741042119, Lot Number: REKY0255). Distribution was nationwide across the United States, including AK, AL, AR, AZ, CA, CO, CT, DC, DE, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, ND, NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, PR, RI, SC, SD, TN, TX, UT, VA, WA, WI, WV, and WY, as well as Belgium.
What You Should Do
Consumers and healthcare providers should follow instructions provided in the firm's notification letter regarding the recalled product.
Why This Matters
This Class II recall involves a device used for temporary vascular access in hemodialysis and related therapies distributed worldwide.
Source
FDA Recall Z-2657-2026 - Event ID 99096, Bard Access Systems, Inc., Salt Lake City, UT.
Original source: FDA Official Notice ↗
Related FDA Recalls
All FDA Recalls →Nationwide notices with similar length or severity timing 8
Two Areazine-derived peer sets for this FDA recall: nearest notices by body length and by same severity near the same agency date. Peers come from other categories so they are not the same-feed Related list above.
Similar body length
Nearest notices by article body length (1,185 characters here).
Similar severity timing
Same severity (medium) notices issued closest in time to August 7, 2026.
Frequently Asked Questions
Common questions about this FDA recall.